Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2009
11/25/2009EP1618106B1 Carbacephem beta-lactam antibiotics
11/25/2009CN101589060A Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
11/25/2009CN101588820A Alpha-lactalbumin composition
11/25/2009CN101586143A Modulating production of pneumococcal capsular polysaccharide
11/25/2009CN101586120A Rabies virus Flury-LEP vaccine strain reverse genetic operating system and LEP green fluorescent protein recombination viral vector
11/25/2009CN101586115A Gene coexpression recombinant plasmid and DNA vaccine prepared from same
11/25/2009CN101585854A New acyclic nucleoside phosphonate compound as well as composition, preparation method and application thereof
11/25/2009CN101585847A Synthetic method of faropenem sodium
11/25/2009CN101585846A Preparation method of faropenem sodium
11/25/2009CN101585843A Process for preparing rifaximin
11/25/2009CN101585836A Novel method for preparing Nevirapine
11/25/2009CN101585820A 1,2,3-selenadiazole thioacetanilides derivatives, preparation method thereof and application thereof
11/25/2009CN101584866A Polyethylene glycol modified human interleukin-2, preparation method and application thereof
11/25/2009CN101584863A Medicament for external use for treating onychomycosis
11/25/2009CN101584861A Methods for enhancing innate and adaptive immunity and antigen immunogenicity
11/25/2009CN101584836A Detoxifying Chinese medicament and preparation method thereof
11/25/2009CN101584827A Traditional Chinese medicine for treating cold in children
11/25/2009CN101584826A Medicament for comprehensively treating a plurality of skin diseases
11/25/2009CN101584818A Traditional Chinese medicine for treating urinary tract infection
11/25/2009CN101584806A Pure traditional Chinese medicine composition for treating avian influenza, preparing method and application thereof
11/25/2009CN101584775A Rehabilitation soup for restraining liver virus
11/25/2009CN101584773A Chinese herbal medicament for treating skin diseases
11/25/2009CN101584751A Antifungal pharmaceutical composition
11/25/2009CN101584747A Antibacterial antivirus Chinese medicinal composition for animal
11/25/2009CN101584745A Preparation for new antivirus Chinese medicine formulation for animal
11/25/2009CN101584735A Pharmaceutical composition for preventing and treating chicken bursal disease and nephrotic bronchitis and preparation method thereof
11/25/2009CN101584734A Medicinal composition for treating hepatitis B and preparation method thereof
11/25/2009CN101584715A Spray for preventing and treating skin damnification and resisting infection
11/25/2009CN101584711A Nano-silver antibacterial washing fluid
11/25/2009CN101584703A Pharmaceutical composition for treating colpitis and preparation method thereof
11/25/2009CN101584702A Method of preparing extract of Mallotus apelta and uses for fighting hepatitis B virus
11/25/2009CN101584701A Antiviral composition
11/25/2009CN101584694A Peptide deformylase inhibitor containing 2, 5-dihydropyrrole and synthesizing method
11/25/2009CN101584679A Novel oral capsule preparation for treating cancer and AIDS
11/25/2009CN101584676A Matrine sustained release preparation and preparing method thereof
11/25/2009CN101584671A Cefazedone sodium medicament powder injection and method for synthesizing raw medicine of Cefazedone sodium
11/25/2009CN101584665A Cefotiam hydrochloride medicament composition sterile powder injection and preparation method thereof
11/25/2009CN101584664A Cefodizime sodium proliposome preparation and preparation method thereof
11/25/2009CN101584658A Preparation method of amikacin sulfate injection
11/25/2009CN101584657A Tilmicosin solution and preparation method thereof
11/25/2009CN101584656A Novel use of amikacin sulfate injection
11/25/2009CN100562342C Oligonucleotide drug for preventing and treating influenza virus infection
11/25/2009CN100562334C Medicinal composition for treating phthisis
11/25/2009CN100562328C Chinese medicinal composition for treating cold
11/24/2009US7622582 Derivatives of 1-phenyl-benzofuro[3,2]pyridin-2(1H)-one
11/24/2009US7622494 Chemical compounds
11/24/2009US7622490 Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors
11/24/2009US7622487 Piperidine derivative, process for producing the same, and use
11/24/2009US7622481 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic
11/24/2009US7622469 2,4-diamino-1,3,5-triazine derivatives
11/24/2009US7622457 Polynucleotides encoding anticoagulant fusion proteins
11/24/2009US7622272 Treating cell proliferation disease; aberrant fetoplacental growth; cancer
11/24/2009US7622124 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant
11/24/2009US7622122 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex
11/24/2009CA2475712C Nicotinamide derivatives useful as pde4 inhibitors
11/24/2009CA2433197C Gyrase inhibitors and uses thereof
11/24/2009CA2423384C New cross-linked derivatives of hyaluronic acid
11/24/2009CA2408144C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/24/2009CA2403831C Coating and binding agent for pharmaceutical formulations having improved storage stability
11/24/2009CA2362153C Antimicrobial/endotoxin neutralizing polypeptide
11/24/2009CA2360039C Beta-d-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine for use in the treatment of hiv infections
11/24/2009CA2343113C Anionic or cationic dendrimer antimicrobial or antiparasitic compositions
11/24/2009CA2341566C Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis
11/24/2009CA2201105C Inhibitor of stem cell proliferation and uses thereof
11/24/2009CA2141574C Herpesvirus vaccines
11/22/2009CA2666450A1 Novel strain of the genus lactobacillus and topical pharmaceutical formulations containing it
11/19/2009WO2009140676A2 Compositions and methods for inhibition of retroviruses
11/19/2009WO2009140500A1 Hepatitis c virus inhibitors
11/19/2009WO2009140475A1 Hepatitis c virus inhibitors
11/19/2009WO2009140287A1 Salinosporamide derivatives as proteasome inhibitors
11/19/2009WO2009140236A2 Staphylococcus aureus-specific antibody preparations
11/19/2009WO2009140215A2 Method for treating drug-resistant bacterial and other infections with clioquinol, phanquinone, and related compounds
11/19/2009WO2009139916A1 Tricyclic triazole compounds that modulate hsp90 activity
11/19/2009WO2009139886A2 Targeting an hiv-1 nef-host cell kinase complex
11/19/2009WO2009139870A1 Oxo-imidazolyl compounds having antibacterial activity
11/19/2009WO2009139792A1 Hcv protease inhibitors
11/19/2009WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009WO2009139181A1 10a-azalide compound having 4-membered ring structure
11/19/2009WO2009139004A2 Tat dna sequences, gene constructs, vaccine and processes thereof
11/19/2009WO2009138860A1 Plant extract and its therapeutic use
11/19/2009WO2009138799A1 Therapeutic uses of 1-cycl0pr0pyl-3 - [3- ( 5 -morpholin- 4 -ylmethyl- 1h-benz0imidaz0l- 2 -yl) -lh-pyrazol-4-yl] -urea
11/19/2009WO2009138519A1 AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME
11/19/2009WO2009138494A2 Amino acid sequences directed against toll-like receptors and polypeptides comprising the same for the treatment of diseases related to toll-like receptors
11/19/2009WO2009137916A1 Processes and intermediates for the preparation of oseltamivir and analogs thereof
11/19/2009WO2009137881A1 Angiogenin-enriched milk fractions
11/19/2009WO2009100723A3 Crystalline forms of an antibiotic substance
11/19/2009WO2009098320A3 Macrolides for treating diseases mediated through pde inhibition
11/19/2009WO2009077586A3 Methods and compositions for the preparation and use of toxin conjugates
11/19/2009WO2009065947A3 Pharmaceutical composition containing a zeolite/algae or zeolite/emulsion combination for the treatment of aids
11/19/2009WO2009046220A3 Lipopeptides for delivery of nucleic acids
11/19/2009WO2009010877A3 Conjugate purification
11/19/2009US20090286958 Interferon-beta fusion proteins and uses
11/19/2009US20090286868 2-Amino-2-oxoethyl trans-3-[5-(naphth-1-yl)-1,3-dioxan-2-yl]propyl carbamate; reacting the phenylcarbonate with 2-aminodioxane; fatty acid amido hydrolase (FAAH) inhibitors; analgesics; nervous system disorders; gastrointestinal disorders,; to name just a few
11/19/2009US20090286855 Interleukin-18 mutants, their production and use
11/19/2009US20090286843 Macrocyclic compounds as inhibitors of viral replication
11/19/2009US20090286841 Certain chemical entities, compositions, and methods
11/19/2009US20090286814 Hcv protease inhibitors
11/19/2009US20090286792 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
11/19/2009US20090286771 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders
11/19/2009US20090286757 Antiviral composition